Investigating the role of the pathophysiological pathways involved in the progression of Parkinson’s disease

UCB is committed in the identification of innovative drugs for the treatment of Parkinson’s disease. One of its objectives is to identify compounds capable to slow down the disease progression. The aim of the project is to better understand how to interfere with  the deleterious a-synuclein configuration, leading to discovery and validation of new therapeutic targets in the area of Parkinson’s disease.

The position requires a PhD level degree in the field of neurosciences, with innovative scientific accomplishment demonstrated by a solid record of publications.

Applicants should demonstrate:

•  Scientific understanding of Parkinson’s disease;
•  Interest in working with rodents;
• Expertise in immunohistochemistry and in in situ hybridization;
• In vivo expertise: surgery, behavioral analysis and post-mortem investigations;
• Critical thinking and creativity.

The applicant is required to have excellent verbal and written communication skills, competence in the English language and a strong motivation to contribute to improving the lives of patients through the creation of breakthrough medicines.

This position is based in Braine l’Alleud, Belgium. Positions are available for a period of 36 months with a starting date during 2012.

To apply for this position, please visit our Job Seekers' section and search for reference BRA00002589.

If you wish to be considered for this position, you are requested to submit a CV and covering letter detailing:

• Your motivation to undertake the chosen post-doctoral programme and passion for that specific area of science
• A detailed description of your scientific career to date
• Names of two referees
• Date from which you would be available